In the TCGA cohort, CHIM samples had higher levels of anti-tumor cells, including CD8+ T cells, M1 macrophages, and CD4+ activated memory T cells, than the other two subtypes, whereas they had lower frequencies of M0 macrophage and CD4+ resting memory T cells (Figure 5A). The gene discussed is CD8A; the disease is neoplasm.